Department of Orthopedics, General Hospital of Chinese PLA, Beijing, 100853, China.
Department of Orthopedics, General Hospital of Liaoyuan Mining Group, Jilin Province, 136201, China.
Biomaterials. 2017 Oct;142:90-100. doi: 10.1016/j.biomaterials.2017.06.024. Epub 2017 Jul 11.
Transplantation of a biosynthetic nerve conduit carrying neuro-protective cytokines is promising for treating peripheral nerve injury. Here we developed a novel strategy for repairing sciatic nerve injury by EPO-loaded Chitosan nerve conduit (EPO/Chi) and sandwiched-in transplantation of mesenchymal stem cells (MSCs). Then, the beneficial effect of EPO/Chi + MSCs on nerve regeneration was also further investigated by in vitro cellular experiments. In vivo experiment showed that combination of EPO-loaded Chitosan nerve conduit with MSCs could significantly accelerate nerve healing and improve morphological repair. Furthermore, the in vitro cellular experiments results demonstrated that the loaded EPO in nerve conduit could significantly reinforce the repair performance of both MSCs and Schwann cells, which may also contribute to the therapeutic outcome of the EPO/Chi + MSCs strategy. Collectively, the EPO-loaded nerve conduit and sandwiched-in transplantation of MSCs we reported in the study may represent a new potential strategy for peripheral nerve reconstruction.
携带神经营养因子的生物合成神经导管移植有望用于治疗周围神经损伤。在这里,我们开发了一种通过载 EPO 壳聚糖神经导管(EPO/Chi)和夹入间充质干细胞(MSCs)移植修复坐骨神经损伤的新策略。然后,通过体外细胞实验进一步研究了 EPO/Chi+MSCs 对神经再生的有益作用。体内实验表明,载 EPO 壳聚糖神经导管与 MSCs 的联合应用可显著加速神经愈合并改善形态修复。此外,体外细胞实验结果表明,神经导管中负载的 EPO 可显著增强 MSCs 和施万细胞的修复性能,这也可能有助于 EPO/Chi+MSCs 策略的治疗效果。总之,我们在研究中报道的载 EPO 神经导管和夹入 MSCs 移植可能代表一种外周神经重建的新的潜在策略。